118 related articles for article (PubMed ID: 7715618)
1. Assessment of micronucleus induction in SCCVII cells treated with bioreductive agents, WIN 59075 (SR 4233) and mitomycin C, under aerobic and hypoxic conditions.
Shibata T; Shibamoto Y; Sasai K; Oya N; Takagi T; Murata R; Abe M
Mutat Res; 1995 Apr; 342(3-4):171-7. PubMed ID: 7715618
[TBL] [Abstract][Full Text] [Related]
2. Effects of bioreductive agents, tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, evaluated by micronucleus assay.
Masunaga S; Ono K; Hori H; Shibata T; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M
Jpn J Cancer Res; 1997 Sep; 88(9):907-14. PubMed ID: 9369940
[TBL] [Abstract][Full Text] [Related]
3. Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay.
Shibata T; Shibamoto Y; Sasai K; Oya N; Murata R; Takagi T; Hiraoka M; Takahashi M; Abe M
Br J Cancer Suppl; 1996 Jul; 27():S61-4. PubMed ID: 8763848
[TBL] [Abstract][Full Text] [Related]
4. The effect of low pH and hypoxia on the cytotoxic effects of SR4233 and mitomycin C in vitro.
Skarsgard LD; Vinczan A; Skwarchuk MW; Chaplin DJ
Int J Radiat Oncol Biol Phys; 1994 May; 29(2):363-7. PubMed ID: 8195034
[TBL] [Abstract][Full Text] [Related]
5. The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
Keohane A; Godden J; Stratford IJ; Adams GE
Br J Cancer; 1990 May; 61(5):722-6. PubMed ID: 2110815
[TBL] [Abstract][Full Text] [Related]
6. Bioreductive metabolism of SR-4233 (WIN 59075) by whole cell suspensions under aerobic and hypoxic conditions: role of the pentose cycle and implications for the mechanism of cytotoxicity observed in air.
Tuttle SW; Hazard L; Koch CJ; Mitchell JB; Coleman CN; Biaglow JE
Int J Radiat Oncol Biol Phys; 1994 May; 29(2):357-62. PubMed ID: 8195033
[TBL] [Abstract][Full Text] [Related]
7. Effect of radiation and tirapazamine (SR-4233) on three melanoma cell lines.
Zhang M; Stevens G
Melanoma Res; 1998 Dec; 8(6):510-5. PubMed ID: 9918413
[TBL] [Abstract][Full Text] [Related]
8. Adaptation of human tumor cells to tirapazamine under aerobic conditions: implications of increased antioxidant enzyme activity to mechanism of aerobic cytotoxicity.
Elwell JH; Siim BG; Evans JW; Brown JM
Biochem Pharmacol; 1997 Jul; 54(2):249-57. PubMed ID: 9271329
[TBL] [Abstract][Full Text] [Related]
9. The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay.
Stratford IJ; Stephens MA
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):973-6. PubMed ID: 2495261
[TBL] [Abstract][Full Text] [Related]
10. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells.
Zeman EM; Brown JM; Lemmon MJ; Hirst VK; Lee WW
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1239-42. PubMed ID: 3744945
[TBL] [Abstract][Full Text] [Related]
11. Tirapazamine (SR 4233) interrupts cell cycle progression and induces apoptosis.
Lin PS; Ho KC; Yang SJ
Cancer Lett; 1996 Aug; 105(2):249-55. PubMed ID: 8697451
[TBL] [Abstract][Full Text] [Related]
12. NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line.
Saunders MP; Patterson AV; Chinje EC; Harris AL; Stratford IJ
Br J Cancer; 2000 Feb; 82(3):651-6. PubMed ID: 10682679
[TBL] [Abstract][Full Text] [Related]
13. Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.
Siim BG; van Zijl PL; Brown JM
Br J Cancer; 1996 Apr; 73(8):952-60. PubMed ID: 8611431
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069.
Patterson AV; Saunders MP; Chinje EC; Talbot DC; Harris AL; Strafford IJ
Br J Cancer; 1997; 76(10):1338-47. PubMed ID: 9374381
[TBL] [Abstract][Full Text] [Related]
15. Combined cytokinesis-block micronucleus and chromosomal aberration assay for the evaluation of radiosensitizers at low radiation doses.
Oya N; Shibamoto Y; Shibata T; Sasai K; Sugiyama T; Abe M
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1153-9. PubMed ID: 7961025
[TBL] [Abstract][Full Text] [Related]
16. Carbogen breathing after irradiation enhances the effectiveness of tirapazamine in SiHa tumors but not SCCVII tumors in mice.
Minchinton AI; Tonn DA; Sutherland DP; Kyle AH
Radiat Res; 2002 Jul; 158(1):94-100. PubMed ID: 12071808
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of the benzotriazine dioxide SR 4233 against human tumour colony-forming units.
Hanauske AR; Ross M; Degen D; Hilsenbeck SG; Von Hoff DD
Eur J Cancer; 1993; 29A(3):423-5. PubMed ID: 8398345
[TBL] [Abstract][Full Text] [Related]
18. Assessment of micronucleus induction in murine SCCVII cells treated with various anticancer agents.
Jeremic B; Shibamoto Y; Abe M
Chemotherapy; 1996; 42(4):266-72. PubMed ID: 8804794
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay.
Shibamoto Y; Streffer C; Sasai K; Oya N; Abe M
Int J Radiat Biol; 1992 Apr; 61(4):473-8. PubMed ID: 1349329
[TBL] [Abstract][Full Text] [Related]
20. The effect of pH on the aerobic and hypoxic cytotoxicity of SR4233 in HT-29 cells.
Skarsgard LD; Skwarchuk MW; Vinczan A; Chaplin DJ
Br J Cancer; 1993 Oct; 68(4):681-3. PubMed ID: 8398693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]